PTGX Protagonist Therapeutics, Inc.
Healthcare$99.19-2.76%ClosedMarket Cap: $6.38B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$115.40
Target (Median)
$117.00
Target Range
$108.00 - $121.00
Upside from current price: 16.3%
Rating Distribution
3 Strong Buy9 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | Wedbush | maintain | Outperform | Outperform |
| 2026-05-06 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-04-15 | Truist Securities | maintain | Buy | Buy |
| 2026-04-07 | Clear Street | maintain | Buy | Buy |
| 2026-03-19 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-03-19 | Citigroup | maintain | Buy | Buy |
| 2026-03-19 | JP Morgan | maintain | Overweight | Overweight |
| 2026-03-19 | Barclays | maintain | Overweight | Overweight |
| 2026-03-03 | Goldman Sachs | maintain | Neutral | Neutral |
| 2026-02-26 | TD Cowen | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.97 | $144.2M | 8 |
| Sun Dec 31 | $1.22 | $282.7M | 5 |
| Mon Dec 31 | $2.65 | $430.1M | 1 |
| Tue Dec 31 | $4.92 | $625.0M | 1 |